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Many traditional systems of medicines employ herbal drugs for the hepatoprotection. Aim of the study
was designed to evaluate the hepatoprotective potential of ‘ethanolic extract of Aquilaria agallocha (沉香
Chen Xiang) leaves' (AAE) against paracetamol (PCM) induced hepatotoxicity in SD rats. Group I animals
were treated with 1% CMC for 8 days. Group II, III, IV and V animals were ﬁrst treated with ‘1% CMC’ 1 ml/
kg/day, AAE 200 mg/kg/day, AAE 400 mg/kg/day and silymarin 100 mg/kg/day respectively for 7 days
and then, orally administered with PCM 3 g/kg b. wt. on 8th day in a single dose. 24 h after the last dosing
by PCM, the blood was obtained through the retro-orbital plexus under light anesthesia and the animals
were sacriﬁced. Hepatoprotective potential was assessed by various biochemical parameters such as ALT,
AST, ALP, LDH, bilirubin, cholesterol, TP and ALB. Group IV rats showed signiﬁcant (p < 0.01) decrease in
ALT, AST, ALP, LDH, cholesterol, bilirubin, liver wt. and relative liver wt. levels while signiﬁcant (p < 0.01)
increase in ﬁnal b. wt., TP and ALB levels as compared to group II rats. Hepatoprotective potential of AAE
400 mg/kg/day was comparable to that of standard drug silymarin 100 mg/kg/day. Results of the study
were well supported by the histopathological observations. This study conﬁrms that AAE possesses
hepatoprotective potential comparable to that of standard drug silymarin as it exhibited comparable
protective potential against PCM induced hepatotoxicity in SD rats.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Aquilaria agallocha (沉 香Chen Xiang) belonging to the family
thymelaeacea is known as Agarwood in English, Agar in Hindi and
Aguru in Sanskrit.1 Agarwood has been utilized for varied purposes
all over the world for thousands of years. Its utilization has been
reported in Ayurveda, Tibetan and traditional East-Asian medical
practice including Susruta Samhita and Shahih Muslim.2,3 Tradi-
tionally the bark, root and leaves of the heartwood of Agarwood are
used for their medicinal properties like aphrodisiac, anodyne, acrid,
astringent, aromatic, cardiotonic, bitter, carminative, fragrant and
stimulant. Agarwood is also used as appetizer, carminative and
mouth freshener and used to treat colic pain, toothache, severe
pains and headache during the pregnancy.4for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).Agar is a pathological product formed by fungal attack of the
host.5 Phytochemical constituents obtained from the Agarwood are
agarol, aquillochin; agarospiranes (sesquiterpines): agarospirol,
baimuxinic acid, baimuxinal, vetaspira-2(11)-6-dien-14-al, vetas-
pira-2(11),6(14)-dien-7-ol, 2,14-epoxyvestipir-6(14)-7-diene, 2,14-
epoxyvestispir-6-ene, 11-hydroxyspirovetiv-1(10)-en-2-one; agar-
ofurans (sesquiterpines): baimuxifuranic acid, dihyro-3,4-
dihydroxyagarofuran, norketoagarofuran, dihydro-4-
hydroxyagarofuran, dihydroagarofuran, b-agarofuran, a-agar-
ofuran, epoxy-b-agarofuran, selina-4,11-dien-14-oic acid, selina-
3,11-dien-14-al, neopetasane and dehydrojinkoheremol.6e15 The
most remarkable bioactive constituents of Agarwood are alkaloids,
steroids, saponins, tannins, terpenoids, ﬂavonoids and phenolic
compounds.16
The plant A. agallocha has several pharmacological activities and
shows antioxidant, antidiabetic, analgesic, antipyretic, anti-
inﬂammatory, antihistaminic, laxative, anticancerous, antidiar-
rhoeal, antidiabetic, antihistaminic, antimicrobial, antibacterial,
anxiolytic, sedative effect, anticonvulsant and ulcer protectiversity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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hepatoprotective potential of ethanolic extract of A. agallocha
leaves against paracetamol (PCM) induced hepatotoxicity in SD
rats, as the drugs having antioxidant and antiulcer activities can
show hepatoprotective activity too.
2. Materials and methods
2.1. Chemicals and instrumentation
All the chemicals used were of analytical grade, silymarin
(Sigma chemicals, USA), paracetamol (SD ﬁne chemical Ltd Mum-
bai, India), ALT test kits (Span Diagnostics Ltd Surat), AST test kits
(Span Diagnostics Ltd Surat), LDH (UV kinetics Accurex Biochemical
Pvt Ltd., Mumbai), albumin test kit (Span Diagnostics Ltd Surat),
bilirubin test kit (Span Diagnostics Ltd Surat), alkaline phosphatase
test kits (Merk Specialities Ltd Mumbai), total protein test kit (Span
Diagnostics Ltd Surat), mini centrifuge (Spinnwell), UV spectro-
photometer (PharmaSpec UV-1700, Shimadzu).
2.2. Collection and authentication of the plant specimen
A. agallocha (沉香Chen Xiang) leaves were procured from Assam
Aromas (police line, GRB road, Fauzdaripatty, Nagaon-782001, As-
sam) and authenticated by the botanists, authentication ofﬁce,
Faculty of Pharmacy, Integral University Lucknow (ref. no.: IU/
PHAR/HRB/15/22). A voucher specimen was deposited to authen-
tication ofﬁce for future reference.
2.3. Preparation of plant extract and evaluation of percentage yield
The dried leaves were subjected to size reduction to a coarse
powder with the help of grinder and powdered material was then
subjected to Soxhlet extraction employing ethanol as solvent. The
extract was concentrated to dryness with the help of rotavapor and
ﬁnally air dried thoroughly to remove all traces of the solvent. The
obtained dried extract (AAE) was weighed and extractive value was
calculated. It was kept in an air tight container in a refrigerator
below 4 C and used for pharmacological investigation.18
2.4. Experimental animals
Sprague-Dawley (SD) rats (150e200 g) were procured from
Animal House, Central Drug Research Institute (CDRI) Lucknow and
kept in departmental animal house, Integral University Lucknow
(IUL). All the rats were housed separately in polypropylene cages at
the 50e60% relative humidity and temperature of 23 ± 2 C with a
12 h light/dark cycle for seven days before and during the
commencement of the experiment. The rats were kept on standard
pellet diet and drinking water throughout the housing period. All
the experiments were conducted in accordance with the guidelines
‘Committee for the Purpose of Control and Supervision’ (CPCSEA)
and ethical clearancewas obtained from Institutional Animal Ethics
Committee (IAEC) of Faculty of Pharmacy, Integral University
Lucknow (Approval No.: IU/PHARM/IAEC/15/06).
2.5. Experimental protocol
The animals were randomly divided into ﬁve groups each con-
sisting of ﬁve rats (n¼ 5). Group I animals were treatedwith vehicle
(1% CMC) for 8 days and served as normal control. Group II animals
were ﬁrst treated with vehicle for 7 days and then, hepatotoxicity
was tried to induce on 8th day by oral administration of PCM 3 g/kg
b. wt. in a single dose.19 Group III, IV and V animals were ﬁrst
treated with AAE 200, AAE 400 and silymarin 100 mg/kg/dayrespectively for 7 days and then, hepatotoxicity was tried to induce
on 8th day by oral administration of PCM 3 g/kg b. wt. in a single
dose. 24 h after the last dosing by PCM, the blood was obtained
through the retro-orbital plexus under light anesthesia and the rats
were sacriﬁced. Serum for the analysis of various biochemical pa-
rameters was separated by centrifugation at 3000 rpm at 4 C for
20 min. The isolated liver tissues were washed twice with ice cold
saline, blotted, dried and then weighed of each group. The relative
liver weight was calculated as percentage ratio of liver weight to
body weight. A small portion of tissue was ﬁxed in formalin for
histopathological examination.
2.6. Assessment of liver function test
Serum alanine transaminase (ALT), aspartate aminotransferase
(AST), alkaline phosphatase (ALP), bilirubin, cholesterol, albumin
(ALB) and total Protein (TP) were estimated by using standard kits
from Span Diagnostic ltd Surat, India. Serum lactate dehydrogenase
(LDH) was estimated by using standard kits from Accurex
biochemical Pvt Ltd, Mumbai, India. All the enzymatic estimations
were assessed as per standard kit methods using UV spectropho-
tometer and the standard kit methods were obtained in detail from
the leaﬂets provided in the commercially kits.
2.7. Histopathological examination
Slices of liver were stored in 10% neutral formalin solution to
preserve them. The tissues weremounted by embedding in parafﬁn
wax in the laboratory and sections of the size of 6 mmwere cut. The
sections were stained with eosin and haemotoxylin dyes. The slides
were observed under light microscope and photomicrographs were
captured by using camera. These were observed for ﬁbrosis, fatty
inﬁltration, centrilobular necrosis and lymphocyte inﬁltration.20
2.8. Statistical analysis
The data was expressed as mean ± standard error of mean
(mean ± SEM). Student's ‘t’ test was followed by individual com-
parison by Newman-Keuls test using graph pad prism software for
determination of level of signiﬁcance. The value of probability less
than 5% (p < 0.05) was considered statistically signiﬁcant.
3. Results
The percentage yield was found to be 23.29% w/w.
Effects of AAE on different liver speciﬁc variables in control and
experimental groups of animals are shown in Table 1. PCM treat-
ment signiﬁcantly (p < 0.01) increased the relative liver weight to
5.52 ± 0.51/100 g body weight (b. wt.) as compared to the normal
control (group I) with that of 3.12 ± 0.81/100 g b. wt. Administra-
tion of AAE 200 and 400 mg/kg signiﬁcantly (AAE 200 mg/kg,
p < 0.05 and AAE 400 mg/kg p < 0.01) reduced the relative liver
weight to 3.57 ± 0.27 and 2.95 ± 0.35/100 g b. wt. respectively as
compared to PCM treatment with that of 5.52 ± 0.51/100 g b.
wt. AAE treated group IV was more close to standard silymarin
treated group V rats at the concentration used. The rats treated
with AAE 400 mg/kg exhibited signiﬁcant change (p < 0.01) in the
ﬁnal b. wt. and relative liver wt. as compared to group II rats.
PCM treated group II rats showed increased serum AST
(315.78 ± 0.99 U/L, p < 0.01), ALT (179.41 ± 8.0 U/L, p < 0.01), ALP
(199.13 ± 1.60 U/L, p < 0.01) and LDH (701.32 ± 2.77 U/L, p < 0.01) as
compared to normal control group I rats (93.26 ± 0.58 U/L,
42.06 ± 1.77 U/L, 65.83 ± 1.26 U/L and 344.60 ± 0.60 U/L respec-
tively). The AAE treated groups III and IV signiﬁcantly decreased
AST (210.68 ± 1.128 U/L, p < 0.05 and 136.75 ± 1.89 U/L, p < 0.01)
Table 1
Effects of ethanolic extract of A. agallocha leaves (AAE) on different liver speciﬁc variables in control and experimental groups of animals.
Treatment groups and
liver speciﬁc variables
I
(Normal control:
1% CMC 1 ml/kg b. wt.)
II
(Hepatotoxic control:
1% CMC 1 ml/kg b. wt.þPCM
3 g/kg b. wt.)
III
(AAE 200 mg/kg b. wt.þPCM
3 g/kg b. wt.)
IV
(AAE 400 mg/kg b. wt.þPCM
3 g/kg b. wt.)
V
(Silymarin
100 mg/kg b. wt.þPCM
3 g/kg b. wt.)
AST (U/L) 93.26 ± 0.58 315.78 ± 0.99# 210.68 ± 1.128* 136.75 ± 1.89** 99.08 ± 2.57**
ALT (U/L) 42.06 ± 1.77 179.41 ± 8.0# 91.46 ± 2.027* 48.25 ± 4.961** 49.79 ± 1.98**
ALP (U/L) 65.83 ± 1.26 199.13 ± 1.60# 102.04 ± 2.86* 89.27 ± 1.18** 76.42 ± 3.08**
LDH (U/L) 344.60 ± 0.60 701.32 ± 2.77# 533.18 ± 28.34* 439.14 ± 27.73** 376.16 ± 7.63**
Bilirubin (mg/dl) 0.19 ± 0.007 1.17 ± 0.069# 1.072 ± .059* 0.41 ± .004** 0.21 ± 0.109**
Cholesterol (mg/dl) 41.06 ± 4.98 77.2 ± 4.06# 60.4 ± 2.85* 52.4 ± 3.18** 39.1 ± 3.40**
ALB (g/dl) 4.04 ± 0.02 2.19 ± 0.07# 3.50 ± 0.16* 4.08 ± 0.06** 4.11 ± 0.05**
TP (g/dl) 6.21 ± 0.265 3.57 ± 0.13# 4.63 ± .072* 5.07 ± 0.40** 5.71 ± 0.13**
Initial b. wt. (g) 180 ± 5.99 163.8 ± 5.19 180 ± 4.04 199 ± 3.13 193.2 ± 1.62
Final b. wt. (g) 205 ± 10.92 157 ± 5.90# 190.2 ± 4.09* 210 ± 7.24** 229.2 ± 6.68**
Liver wt. (g) 6.09 ± 0.32 8.64 ± 0.62# 6.98 ± 0.59ns 6.21 ± 0.23** 6.08 ± 0.40**
Relative liver wt.
(Liver wt./100 g b. wt.)
3.12 ± 0.08 5.52 ± 0.51# 3.57 ± 0.27* 2.95 ± 0.35** 2.54 ± 0.092**
Values were expressed as mean ± SEM (n ¼ 5), where, # indicates p < 0.01 as compared with respective control group I; ns indicates p > 0.05, *p < 0.05, **p < 0.01 as compared
with respective group II.
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ALP (102.04 ± 2.86 U/L, p < 0.05 and 89.27 ± 1.18 U/L, p < 0.01) and
LDH (533.18 ± 28.34 U/L, p < 0.05 and 439.19 ± 27.73 U/L, p < 0.01
respectively) as compared to group II. Silymarin at 100 mg/kg
signiﬁcantly (p < 0.01) declined the elevated levels of AST, ALT, ALP
and LDH to the levels of 99.08 ± 2.57 U/L, 49.79 ± 1.98 U/L,
76.42 ± 3.08 U/L and 376.16 ± 7.84 U/L respectively as compared to
PCM treated group II.
PCM treated group II showed signiﬁcantly (p < 0.01) decreased
serum ALB (2.19 ± 0.07 g/dl) and TP (3.57 ± 0.13 g/dl) while,
increased bilirubin (1.17 ± 0.069 mg/dl) and cholesterol
(77.2 ± 4.06 mg/dl) as compared to control group I (4.04 ± 0.02 g/dl,
6.21 ± 0.265 g/dl, 0.19 ± 0.007 mg/dl and 41.06 ± 4.98 mg/dl
respectively). The AAE treated groups III and IV signiﬁcantly
increased serum ALB (3.50 ± 0.16, p < 0.05 and 4.08 ± 0.06 g/dl,
p < 0.01) and TP (4.63 ± .072, p < 0.05 and 5.07 ± 0.40 g/dl, p < 0.01)
while, decreased bilirubin (1.172 ± .059, p < 0.05 and
0.41 ± .004 mg/dl, p < 0.01) and cholesterol (60.4 ± 2.85, p < 0.05
and 52.4 ± 3.18 mg/dl, p < 0.01 respectively) as compared to group
II. Silymarin at 100 mg/kg signiﬁcantly (p < 0.01) increased the ALB
(4.11 ± 0.05 g/dl) and TP (5.71 ± 0.13 g/dl), while decreased theFig. 1. Gross anatomy of liver in control and experimental groups of rats: Group I is with
the groups (III, IV and V) indicated recovery of damage cells towards normal.bilirubin (0.21 ± 0.109 mg/dl) and cholesterol (39.1 ± 3.40 mg/dl) as
compared to PCM treated group II.
The effects of AAE on the gross anatomy of liver are shown in
Fig. 1 and on histopathology of liver in Fig. 2.
4. Discussion
Paracetamol (PCM) is an analgesic and antipyretic drug which,
when taken in at toxic doses, becomes a potent hepatotoxic sub-
stance liberating fulminated renal tubular and hepatic necrosis
lethal to experimental animals and humans.21,22 Its overdose can
cause liver function failure, centrilobular hepatic necrosis and even
death in experimental animals as well as human.23 The laboratory
features of PCM induced hepatotoxicity is similar to other kinds of
acute inﬂammation and liver ailment with major increase of AST,
ALP, ALT, LDH, cholesterol, bilirubin and decrease of ALB and TP.24
Results of the study clearly demonstrated that the serum level of
hepatic enzymes AST, ALP, ALT, LDH, cholesterol, bilirubin were
increased, and ALB, TP were decreased in the present study,
reﬂecting the hepatocellular damage in the PCM induced hepato-
toxicity in animal model.normal appearance. Marks in group (II) indicated damage of liver cells. Marks in rest of
Fig. 2. Histopathologicy of liver tissues in control and experimental groups of rats. (I) Normal control group: showed the well deﬁned architecture and vesicular nuclei. (II)
Hepatotoxic group: showed degenerative changes in hepatocytes and necrosis occurred. (III) Group treated with AAE 200 mg/kg: showed proliferative hepatocytes with mild
degenerative changes and increased inter cellular space. (IV) Group treated with AAE 400 mg/kg: showed normal architecture and well deﬁned nuclei when compared with group I.
(V) Group treated with silymarin 100 mg/kg: section showed normal architecture with well deﬁned nucleus.
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acute toxicity according to OECD (Organization for Economic Co-
operation and Development) 423 guidelines upto the dose of
2000mg/kg b. wt. was found to be non-toxic and safe.25 Hence, two
dose levels of as low 200 mg/kg and high 400 mg/kg of AAE were
selected here for the experiment.
AAE at the doses of 200 and 400 mg/kg signiﬁcantly (p < 0.05 to
p < 0.01) lowered the AST, ALP, ALT, LDH, cholesterol and bilirubin
in these PCM intoxicated rats. The results of liver function tests
were correlated to the histopathological changes from photomi-
crographs taken. The centrilobular hepatic necrosis, cell degener-
ation and inﬁltrating lymphocytes were well displayed in PCM
intoxicated group II. Treatment with AAE prevented these PCM
induced histopathological changes. These results suggested that
the inhibition of elevated hepatic damage and hepatic function
markers may participate in the protective effect of the AAE against
PCM induced hepatotoxicity.
The hepatoprotection by AAE may be due to antioxidant prop-
erty of the phytochemicals present in AAE which reduce the
oxidative stress imposed by PCM and other like anti-inﬂammatory
and analgesic properties preventing the inﬂammatory hepatic
damage.26,27
5. Conclusion
Ethanolic extract of A. agallocha leaves (AAE) possesses hep-
atoprotective effect as it exhibited protective effect against para-
cetamol induced hepatotoxicity in SD rats demonstrated by
signiﬁcant decrease in AST, ALT, ALP, LDH, cholesterol, bilirubin and
increase in ALB, TP concentration, and prevention of PCM induced
histopathological changes in liver.
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